Captabine Tablet

Captabine 150 mg Tablet সম্পর্কে

Captabine 150 mg Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Capecitabine এবং শক্তি ১৫০ mg। Captabine-এর সাথে Capecitabine-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ঔষধটি Cytotoxic Chemotherapy শ্রেণির অন্তর্ভুক্ত। Captabine-এর প্রতি ইউনিটের দাম ৩০.০০ টাকা। Captabine প্রস্তুত করেছে Techno Drugs Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Capecitabine-এর ৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Captabine এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি।

Captabine 150 mg Tablet কী?

Captabine comes as a tablet with 150 mg of Capecitabine, from Techno Drugs Ltd. It contains Capecitabine, a cytotoxic chemotherapy medicine. Capecitabine is a prodrug, which means the body converts it into an active substance that interferes with DNA synthesis and slows tumour growth. The doctor decides whether it is suitable, the dose, and the length of the course.

Captabine-এর ব্যবহার

Capecitabine is used to treat some types of cancer. Do not use it for any other condition, and ask the doctor if you are unsure what it is being used for in your case. Your cancer specialist will explain why it has been prescribed for you. Ask your doctor whether it is right for your condition.

Captabine কীভাবে ব্যবহার করবেন

Never change the dose or stop on your own. Swallow the tablet with water. Captabine is taken by mouth. Swallow the tablet as your doctor or pharmacist advises. If you miss a dose or vomit after taking it, ask your doctor or pharmacist what to do. Complete the course exactly as prescribed.

Captabine-এর পার্শ্বপ্রতিক্রিয়া

Seek urgent help for severe or worsening symptoms. Some people have serious skin reactions. Common side effects include nausea, vomiting, diarrhoea, stomach pain, mouth sores, loss of appetite, tiredness, rash, dry or itchy skin, fever, infection, chest pain and a hand-and-foot skin reaction. Contact your doctor if you notice anything unusual after taking it. Your doctor will explain which effects need immediate attention and how they should be managed.

সতর্কতা ও নিরাপত্তা

It can harm an unborn baby, so pregnancy should be avoided during treatment; breastfeeding must stop during treatment and for a time afterwards. It is not for people with severe kidney problems, low blood cell counts, serious reactions to fluoropyrimidine therapy, complete DPD deficiency, or allergy to the medicine. People with heart disease or bleeding problems should be checked first. Tell your doctor about all your other medicines before starting, because Capecitabine can interact with blood thinners, phenytoin, leucovorin and some other drugs.

সাধারণ প্রশ্ন

What is Captabine used for?

Capecitabine is used to treat some types of cancer. Do not use it for any other condition, and ask the doctor if you are unsure what it is being used for in your case.

How do I use Captabine correctly?

Never change the dose or stop on your own. Swallow the tablet with water.

What should I watch for while using Captabine?

Seek urgent help for severe or worsening symptoms. Some people have serious skin reactions.

What is the price of Captabine?

The listed price is ৳ ৩০.০০.

Tablet
জেনেরিক নাম
Capecitabine
শক্তি
150 mg
ডোজ ফর্ম
Tablet
প্রস্তুতকারক
Techno Drugs Ltd.
থেরাপিউটিক ক্লাস
Cytotoxic Chemotherapy
বাংলাদেশে দাম

৳ ২৯.৪ ৳ ৩০.০০ ২% ছাড় প্রতি ইউনিট

দাম হালনাগাদ: ১৮ Nov ২০২৬

আরও পাওয়া যায়

500 mg (Tablet)

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for:
  • Adjuvant Colon Cancer: Patients with Dukes'C colon cancer.
  • Metastatic Colorectal Cancer: First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred.
  • ... Read more
Capecitabine is a nucleoside metabolic inhibitor with antineoplastic activity indicated for:
  • Adjuvant Colon Cancer: Patients with Dukes'C colon cancer.
  • Metastatic Colorectal Cancer: First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred.
  • Metastatic Breast Cancer: In combination with docetaxel after failure of prior anthracycline containing therapy.
  • As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Capecitabine is a preparation of Capecitabine, an orally-administered chemotherapeutic agent used in the treatment of cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumour, where it inhibits DNA synthesis and slows growth of tumour tissue.

Capecitabine is a prodrug that is selectively tumour-activated to its cytotoxic moiety, fluorouracil, by thymidine phosphorylase, an enzyme found in higher concentrations in many tumours compared to normal tissues or plasma. Fluorouracil is further metabolized to two active metabolites, 5-fluoro-2'-deoxyuridine 5-monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP), within normal and tumour cells. These metabolites cause cell injury by two different mechanisms. First, FdUMP and the folate cofactor, N5-10 methylenetetrahydrofolate, bind to thymidylate synthase (TS) to form a covalently bound ternary complex. This binding inhibits the formation of thymidylate from 2-deoxyuridylate. Thymidylate is the necessary precursor of thymidine triphosphate, which is essential for the synthesis of DNA, therefore a deficiency of this compound can inhibit cell division. Secondly, nuclear transcriptional enzymes can mistakenly incorporate FUTP in place of uridine triphosphate (UTP) during the synthesis of RNA. This metabolic error can interfere with RNA processing and protein synthesis through the production of fraudulent RNA.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Monotherapy: 1250 mg/m2 twice daily orally for 2 weeks followed by a one-week rest period in 3-week cycles

Adjuvant treatment: Is recommended for a total of 6 months (8 cycles)

In combination with docetaxel: The recommended dose of Capecitabine is 1250 mg/m2 twice daily for 2 weeks followed by a 7-day rest period, combined with docetaxel at 75 mg/m2 as a 1-hour IV infusion every 3 weeks. Capecitabine dosage may need to be individualized to optimize patient management. Capecitabine dosage has to be reduced by 25% in patients with moderate renal impairment.

Example: A person whose body weight is 64 kg and height is 1.64 m has a body surface area of 1.7 m2 and should take 4 tablets of 500 mg and 1 tablet of 150 mg two times daily.

The tablets should be taken in morning and evening as prescribed by doctor. The tablets should be taken within 30 minutes after the end of a meal (breakfast and dinner) and swallowed whole with water. Tablets should not be cut or crushed. Capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Anticoagulants: Anticoagulant response (INR or prothrombin time) should be monitored frequently in order to adjust the anticoagulant dose as needed.
  • Phenytoin: Phenytoin levels should be monitored in patients taking Capecitabine concomitantly with phenytoin. The phenytoin dose may need to be reduced.
  • Leucovorin: The concentration of 5-fluorouracil is increased and its toxicity may be enhanced by leucovorin.
  • CYP2C9 substrates: Care should be exercised when Capecitabine is co-administered with CYP2C9 substrates.
  • Food: Reduced both the rate and extent of absorption of Capecitabine.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Severe Renal Impairment
  • Hypersensitivity
  • leucopenia, neutropenia or thrombocytopenia
  • Severe reactions to fluoropyrimidine therapy
  • Complete DPD deficiency
  • Pregnant or breast-feeding

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Abdominal pain, Rash, dry or itchy skin, Tiredness, loss of appetite (anorexia), Diarrhea, Vomiting, Nausea, Stomatitis, Hand-and-foot skin-reaction, Fever, Infection, Chest pain, Steven-Johnson syndrome

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy category D. Capecitabine can cause fetal harm. Women are advised of the potential risk to the fetus. It is not known whether Capecitabine is excreted in human breast milk.No studies have been conducted to assess the impact of Capecitabine on milk production or its presence in human breast milk. As the potential for harm to the nursing infant is unknown, breast-feeding should be discontinued while receiving treatment with Capecitabine and for 2 weeks after the final dose.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Coagulopathy: Anticoagulant response should be monitored (e.g. INR) and anticoagulant dose must be adjusted accordingly. Otherwise may result in bleeding, death.

Diarrhea: Capecitabine treatment should be stopped immediately until diarrhea resolves or decreases to grade 1. Standard antidiarrheal treatments recommended. Otherwise may get severe.

Cardiotoxicity: Common in patients with a prior history of coronary artery disease.

Increased Risk of Severe or Fatal Adverse Reactions in Patients with Low or Absent Dihydropyrimidine Dehydrogenase (DPD) Activity: Capecitabine should be withhold or permanently discontinued in patients with evidence of acute early-onset or unusually severe toxicity, which may indicate near complete or total absence of DPD activity.

Dehydration and Renal Failure: Capecitabine treatment should be stopped until dehydration is corrected. Potential risk of acute renal failure secondary to dehydration.

Mucocutaneous and Dermatologic Toxicity: Severe mucocutaneous reactions, Steven-Johnson Syndrome. (SJS) and Toxic Epidermal Necrolysis (TEN), have been reported. Capecitabine should be permanently discontinued in patients who experience a severe mucocutaneous reaction during treatment. Capecitabine may induce hand-and-foot syndrome. Capecitabine treatment should be interrupted until the hand-and-foot syndrome event resolves or decreases in intensity.

Hyperbilirubinemia: Capecitabine treatment should be interrupted immediately until the hyperbilirubinemia resolves or decreases in intensity.

Hematologic: Patients should not be treated with neutrophil counts <1.5x109/L or thrombocyte counts <100x109/L.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

The manifestations of acute overdose include nausea, vomiting, diarrhea, mucositis, gastrointestinal irritation and bleeding, and bone marrow depression. Medical management of overdose should include customary therapeutic and supportive medical interventions aimed at correcting the presenting clinical manifestations and preventing their possible complications.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep in a dry place and store below 30°C. Protect from light and keep out of the reach of children.

বিকল্প ব্র্যান্ড: Capecitabine

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Capcitab Tablet

150 mg

Capecitabine

Eskayef Pharmaceuticals Ltd.

৳ ৫৮.৮ ৳ ৬০.০০ ২% ছাড় প্রতি ইউনিট

Captabine Tablet

500 mg

Capecitabine

Techno Drugs Ltd.

৳ ৮৮.২ ৳ ৯০.০০ ২% ছাড় প্রতি ইউনিট

Cabita Tablet

500 mg

Capecitabine

Drug International Ltd.

৳ ১০৭.৮ ৳ ১১০.০০ ২% ছাড় প্রতি ইউনিট

Capecitin Tablet

500 mg

Capecitabine

Aristopharma Ltd.

৳ ১১৭.৬ ৳ ১২০.০০ ২% ছাড় প্রতি ইউনিট

Caparen Tablet

500 mg

Capecitabine

Renata Limited

৳ ১২২.৫ ৳ ১২৫.০০ ২% ছাড় প্রতি ইউনিট

Capcitab Tablet

500 mg

Capecitabine

Eskayef Pharmaceuticals Ltd.

৳ ১২২.৫ ৳ ১২৫.০০ ২% ছাড় প্রতি ইউনিট

Syntabine 500 mg Tablet

500 mg

Capecitabine

Synovia Pharma PLC.

৳ ১৩৭.২ ৳ ১৪০ ২% ছাড় প্রতি ইউনিট

Capixet Tablet

500 mg

Capecitabine

Everest Pharmaceuticals Ltd.

৳ ১৪২.১ ৳ ১৪৫.০০ ২% ছাড় প্রতি ইউনিট

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।